Sorry for the longer than usual blogging hiatus. But three weeks ago I started a new job at a small software company in Palo Alto, CA. It’s still very surreal for me to think I now work in corporate America. As recently as August I was sure I would remain in policy my whole life. Only a fortuitous sequence of events changed my outlook. I’m absolutely loving it so far and don’t mind the long hours.
If you want to know know what I do (and didn’t get the reference in the title), the video above pretty much summarizes it.
Unfortunately, this youthful enthusiasm and hard work means blogging will take a bit of a break. I figure it will be at least another week or two before I figure out my schedule and thinks slow down a bit.
To not completely leave you empty-handed, here’s Daniel Engber’s fantastic essay on the flawed use of mice in biomedical research:
When Mattson made that point in Atlanta, and suggested that the control animals used in labs were sedentary and overweight as a rule, several in the audience gasped. His implication was clear: The basic tool of biomedicine—and its workhorse in the production of new drugs and other treatments—had been transformed into a shoddy, industrial product. Researchers in the United States and abroad were drawing the bulk of their conclusions about the nature of human disease—and about Nature itself—from an organism that’s as divorced from its natural state as feedlot cattle or oven-stuffer chickens.